Sensei Biotherapeutics: Jumps 30% in Nasdaq debut

Faeth Therapeutics,

04/02/2021 18:17

** Shares of Sensei Biotherapeutics  SNSE.O  rise 30% to
$24.7 in Nasdaq debut
    ** At the opening price, SNSE was valued at over $702.5 mln 
    ** Co's IPO was priced at $19 per share
    ** Co offered ~7 mln shares in IPO, raising over $133 mln
 urn:newsml:reuters.com:*:nGNX7CrW0Z
    ** SNSE is clinical-stage biotech co, focused on developing
immunotherapy-based treatments for cancer
    ** Citigroup, Piper Sandler and Berenberg are joint
book-running managers for offering

 (Reporting by Sohini Podder in Bengaluru)
 ((sohini.podder@thomsonreuters.com))